Stage IVA Thyroid Gland Follicular Carcinoma
1 clinical trials · Condition
◉ Watch Stage IVA Thyroid Gland Follicular Carcinoma
| Record | Firm | Date |
|---|---|---|
| Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer (NCT01811212) | National Cancer Institute (NCI) | 2013-05-08 |
Track Stage IVA Thyroid Gland Follicular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.